v3.26.1
Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited) - CAD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Profit or loss [abstract]    
Revenue $ 239,289 $ 202,692
Cost of revenue (179,482) (187,707)
Gross profit 59,807 14,985
Consulting and marketing 343,213 495,447
Research and development 88,446 844,769
Depreciation and amortization 127 660
Share-based compensation 663,252
General and administrative expenses 419,982 464,293
Professional fees 282,969 661,956
Total operating expense  1,134,737 3,130,377
Loss before other income (expense) (1,074,930) (3,115,392)
Other income (expense)    
Loss from warrants revaluation (7,314,179)
Loss from settlement agreement revaluation (128,100)
Foreign exchange gain (loss) 13,364 (141,162)
Finance income (expenses), net 152,906 26,965
Other income (expense)  166,270 (7,556,476)
Loss before tax (908,660) (10,671,868)
Tax expense (5,551)
Loss for the period (908,660) (10,677,419)
Other comprehensive income    
Exchange differences on translation of foreign operations 234,169 46,245
Remeasurement of a defined benefit plan, net 14,017 2,620
Other comprehensive income for the period 248,186 48,865
Total comprehensive loss $ (660,474) $ (10,628,554)
loss per share - basic [1] $ (1.05) $ (3,586)
loss per share - diluted [1] $ (1.05) $ (3,586)
Weighted average shares outstanding - basic 862,997 2,977
Weighted average shares outstanding - diluted 862,997 2,977
[1] Adjusted to reflect one (1) for five hundreds (500) reverse stock split in April 2025 (see Note 1)